Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 20, Pages 4970
Publisher
MDPI AG
Online
2022-10-11
DOI
10.3390/cancers14204970
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
- (2022) Yuichiro Doki et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
- (2022) Zi-Xian Wang et al. CANCER CELL
- Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes
- (2021) Chaoqi Zhang et al. Frontiers in Cell and Developmental Biology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Prognostic Signature Based on Immunogenomic Profiling Offers Guidance for Esophageal Squamous Cell Cancer Treatment
- (2021) Jianyao Gao et al. Frontiers in Oncology
- Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
- (2021) Huiyan Luo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
- (2021) Jong-Mu Sun et al. LANCET
- Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting
- (2021) Wei Liu et al. Nature Communications
- Pan-cancer single-cell landscape of tumor-infiltrating T cells
- (2021) Liangtao Zheng et al. SCIENCE
- Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma
- (2021) Jiannan Yao et al. Frontiers in Oncology
- Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)
- (2020) M. Moehler et al. ANNALS OF ONCOLOGY
- Large-scale public data reuse to model immunotherapy response and resistance
- (2020) Jingxin Fu et al. Genome Medicine
- ImmuCellAI: A Unique Method for Comprehensive T‐Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy
- (2020) Ya‐Ru Miao et al. Advanced Science
- The Combination Options and Predictive Biomarkers of PD-1/PD-L1 Inhibitors in Esophageal Cancer
- (2020) Hui Yang et al. Frontiers in Oncology
- Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients
- (2020) Lin Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China
- (2020) Yutong He et al. Cancer Communications
- Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment
- (2020) Yingxia Zheng et al. Nature Communications
- Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation
- (2020) Elizabeth C. Paver et al. PATHOLOGY
- PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population
- (2019) Lulu Rong et al. Diagnostic Pathology
- Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas
- (2019) Tong Lu et al. Cancer Cell International
- Interleukin‐33‐nuclear factor‐κB‐CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells
- (2019) Ying Yue et al. CANCER SCIENCE
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
- (2018) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- A seven-lncRNA signature predicts overall survival in esophageal squamous cell carcinoma
- (2018) Yu Mao et al. Scientific Reports
- Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study
- (2015) Su Jin Lee et al. BMC CANCER
- Mitoxantrone, More than Just Another Topoisomerase II Poison
- (2015) Benny J. Evison et al. MEDICINAL RESEARCH REVIEWS
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Building Predictive Models inRUsing thecaretPackage
- (2015) Max Kuhn Journal of Statistical Software
- Clinical study on postoperative recurrence in patients with pN0 esophageal squamous cell carcinoma
- (2014) Xu-feng Guo et al. Journal of Cardiothoracic Surgery
- Similarity network fusion for aggregating data types on a genomic scale
- (2014) Bo Wang et al. NATURE METHODS
- Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
- (2013) Edward Y Chen et al. BMC BIOINFORMATICS
- Lynx: a database and knowledge extraction engine for integrative medicine
- (2013) Dinanath Sulakhe et al. NUCLEIC ACIDS RESEARCH
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search